Skip to main content
Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.780
+0.020 (2.60%)
At close: Nov 20, 2024, 4:00 PM
0.746
-0.034 (-4.37%)
Pre-market: Nov 21, 2024, 7:14 AM EST

Biofrontera Revenue

Biofrontera had revenue of $9.01M in the quarter ending September 30, 2024, with 1.30% growth. This brings the company's revenue in the last twelve months to $35.36M, up 5.17% year-over-year. In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth.

Revenue (ttm)
$35.36M
Revenue Growth
+5.17%
P/S Ratio
0.09
Revenue / Employee
$415,976
Employees
85
Market Cap
4.32M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonoma Pharmaceuticals 13.55M
Predictive Oncology 1.48M
Aptorum Group 431.38K
Cyclerion Therapeutics 194.00K
Silo Pharma 72.10K
Creative Medical Technology Holdings 11.00K
Revenue Rankings

BFRI News

More News